<< Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list for depression treatment | Halozyme identifies strategy to reintroduce HYLENEX >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Filipino | Ελληνικά | עִבְרִית | Bahasa | Norsk | Русский | Svenska | Polski

Pathology experts to evaluate medical, surgical breast cancer treatment at World Senologyc Congress

Published on August 31, 2010 at 8:14 AM · No Comments

Spain will held the 16th World Senologyc Congress between the 20th and 22nd of October. This meeting will allow doctors to evaluate the progress achieved in medical and surgical breast cancer treatment and its future challenges. The best time to rebuilding breasts, how to preserve patients' fertility, the use of nodes self-transplant to treat lymphedema, the develop of new molecular targets and the use of stem cells will be some of the key issues to be treated during the congress.

Over 1.500 breast pathology experts will meet between the 20th and 22nd of October in the 16th World Congress of the Senologic International Society (SIS). This meeting and the 29th Congress of the Spanish Society of Senology and Breast Diseases (SESPM) will take place in the Valencia, coinciding with the International Breast Cancer Day.

According to Dr. Carlos Vázquez, president of the SIS and the SESPM, "this meeting will allow us to update the new advances in breast surgery, specially regarding to the sentinel node biopsy, and to study in depth the latest breast immediate rebuilding techniques and  radiotherapy standards". "We will also have the chance to asses with worldwide renowned experts about the radiology diagnosis methodology and its possible uses in life surgery", he adds.

From a socio-sanitary point of view, the congress' members will evaluate the efficacy of breast cancer screening using mammography and they will check the results obtain by the hospital breast units in terms of survival and quality of life. These structures allow patients to receive a complete and multidisciplinary management of their tumor.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading